Eiger BioPharma to Present Its Hepatitis Delta Virus Development Program at EASL Meeting
News
Eiger BioPharmaceuticals announced that studies from its Hepatitis Delta Virus (HDV) development program will be presented at the upcoming European Association for the Study of the Liver (EASL) conference April 13-17 in Barcelona, Spain. Also, interim ... Read more